France · Source-listed medicine information

France / CIS 62154820

FINTEPLA 2,2 mg/mL, solution buvable

solution buvable · orale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution buvable
Routeorale
Ingredient entries2
CountryFrance

Product identity

At a glance

Authorisation holder
UCB PHARMA BELGIQUE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 62154820

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for FINTEPLA 2,2 mg/mL, solution buvable
IngredientStrength / referenceSource role
CHLORHYDRATE DE FENFLURAMINEsolution2,32 mg1 mL de solutionSAGroup 1
FENFLURAMINEsolution2,2 mg1 mL de solutionFTGroup 1

Pack references

Presentations (3)

1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flacon

CIP13 3400930224359

Présentation active · Déclaration de commercialisation
1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flacon

CIP13 3400930224366

Présentation active · Déclaration de commercialisation
1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 360 mL + 4 seringues pour administration orale ( 2 x 3 mL et 2 x 6 mL ) + 1 adaptateur de flacon

CIP13 3400930224373

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 62154820 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →